Clinical Trial Detail

NCT ID NCT04229979
Title GPS Compared With BAT in AML CR2/CR2p
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sellas Life Sciences Group
Indications

acute myeloid leukemia

Therapies

Galinpepimut-S

Cytarabine

Decitabine

Venetoclax

Azacitidine

Age Groups: senior adult

No variant requirements are available.